Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

In this study, we demonstrate a refined single fiber electromyography (SFEMG) protocol to allow in vivo measurement of neuromuscular junction (NMJ) transmission in rodent models. A step-by-step approach to the SFEMG technique is described to allow quantification of NMJ transmission variability and failure in rat gastrocnemius muscle.

Abstract

As the final connection between the nervous system and muscle, transmission at the neuromuscular junction (NMJ) is crucial for normal motor function. Single fiber electromyography (SFEMG) is a clinically relevant and sensitive technique that measures single muscle fiber action potential responses during voluntary contractions or nerve stimulations to assess NMJ transmission. The assessment and quantification of NMJ transmission involves two parameters: jitter and blocking. Jitter refers to the variability in timing (latency) between consecutive single-fiber action potentials (SFAPs). Blocking signifies the failure of NMJ transmission to initiate an SFAP response. Although SFEMG is a well-established and sensitive test in clinical settings, its application in preclinical research has been relatively infrequent. This report outlines the steps and criteria employed in performing stimulated SFEMG to quantify jitter and blocking in rodent models. This technique can be used in preclinical and clinical studies to gain insights into NMJ function in the context of health, aging, and disease.

Introduction

Single fiber electromyography (SFEMG) was initially developed by Stålberg and Ekstedt in the 1960s to identify and analyze action potentials from individual muscle fibers, primarily to study muscle fatigue1. SFEMG is the most sensitive clinical technique for the assessment of neuromuscular junction (NMJ) transmission2. SFEMG is conducted by selectively recording single fiber action potentials (SFAPs)3. NMJ transmission can be compromised due to factors like aging4,5 and various neuromuscular disorders such as mya....

Protocol

All protocols were approved and performed in accordance with the regulations set forth by the Institutional Animal Care and Use Committee at the University of Missouri.

1. Animal preparation and anesthesia administration

  1. Put on appropriate personal protection equipment.
  2. Prior to the procedure, measure the rat's weight to determine the appropriate dose for weight-based medications and ventilator settings.
  3. Induce anesthesia with 3%-5% inhaled .......

Representative Results

To demonstrate increased jitter and blocking in the context of NMJ transmission failure, stimulated SFEMG was performed with and without intravenous administration of rocuronium. Rocuronium is an intermediate-acting, non-depolarizing neuromuscular blocking agent widely used in clinical settings to induce muscle paralysis during surgeries or medical procedures. It operates by competitively binding to nicotinic acetylcholine receptors at the NMJ19. Prior to the administration of rocuronium, the adul.......

Discussion

SFEMG is commonly used for diagnostic testing in patients with suspected autoimmune, acquired, and genetic forms of NMJ disease. SFEMG is considered the most sensitive test for the diagnosis of the NMJ disorder, myasthenia gravis20,21. Repetitive nerve stimulation (RNS) is another method that is more commonly used in clinical diagnostic testing and involves stimulating a peripheral nerve with a train of stimuli and quantifying the summated compound muscle action .......

Acknowledgements

The authors would like to thank Dr. Martin Brandhøj Skov from NMD Pharma for his valuable advice on rocuronium dosing and Arash Karimi from the Biomedical Engineering Department of Stony Brook University for his assistance in calculations. This study was supported in part by funding from NIH to WDA (R01AG067758 and R01AG078129).

....

Materials

NameCompanyCatalog NumberComments
 27 G Reusable Single Fiber Needle ElectrodeTechnomed202860-000singlefiber recording electrode
2 mL Glass SyringeKent Scientific CorporationSOMNO-2ML
Detachable CableTechnomed202845-0000to connect the recorder electrode to the electrodiagnostic machine
Disposable 2" x 2" disc electrode with leadsCadwell302290-000ground electrode
disposable monopolar needles 28 GTechnomed202270-000cathode and anode stimulating electrodes
EMG needle cable (Amp/stim switch box)Cadwell190266-200to connect monopolar electrodes to electrodiagnostic stimulator
Helping Hands alligator clip with iron baseRadio Shack64-079Maintaining recording electrode placement 
Isoflurane (250 mL bottle)Piramal HealthcareNA
monoject curved tip irrigating syringeCovidien81412012utilized for application of electrode gel
PhysioSuite Physiological Monitoring System with RightTemp Homeothermic WarmingKent Scientific CorporationPS-RTIncludes infrared warming pad, rectal probe, and pad temperature probe
Pro trimmer Pet Grooming KitOster078577-010-003clippers for hair removal
Rat Endotracheal Tubes (16 G)Kent Scientific Corporation
Rocoronium BromideSigmaPHR2397-500MGneuromuscular blocker agent
Sierra Summit EMG systemCadwell Industries, Inc., Kennewick, WANAportable electrodiagnostic system
SomnoSuite Low-Flow Digital Anesthesia SystemKent Scientific CorporationSOMNOIncludes anti-spill, anti-vapor bottle top adapter; Y adapter tubing; charcoal scavenging filter
Veterinarian petroleum-based ophthalmic ointment Puralube26870applied during anesthesia to avoid corneal injury

References

  1. Stalberg, E. Propagation velocity in human muscle fibers in situ. Acta Physiol Scand Suppl. 287, 1-112 (1966).
  2. Stålberg, E., Trontelj, J. V. The study of normal and abnormal neuromuscular transmission ....

Explore More Articles

SFEMGSingle Fiber ElectromyographyNeuromuscular JunctionNMJJitterBlockingRodent ModelMotor FunctionPreclinical ResearchNerve StimulationMuscle Fiber Action Potential

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved